Applied DNA Sciences, Inc. (APDN)
After hours:
| Previous Close | 1.3900 |
| Open | 1.3700 |
| Bid | 1.2800 x 3000 |
| Ask | 1.3400 x 1300 |
| Day's Range | 1.2500 - 1.3900 |
| 52 Week Range | 1.0800 - 8.1000 |
| Volume | |
| Avg. Volume | 66,985 |
| Market Cap | 10.458M |
| Beta (5Y Monthly) | 1.10 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.9060 |
| Earnings Date | Aug 10, 2022 - Aug 15, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.33 |
- Zacks
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
STONY BROOK, N.Y., May 12, 2022--Revenues at Record $6.2 Million, up 130% Year-over-Year; Cash at $6.5 Million Inclusive of Net Proceeds from Offering and Strong Cash Collections.
- Business Wire
Applied DNA Schedules Fiscal 2022 Second Quarter Financial Results Conference Call and Webcast for Thursday, May 12, 2022
STONY BROOK, N.Y., May 09, 2022--Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in cell-free, enzymatic DNA production, today announced that it will report fiscal 2022 second quarter financial results after market close on Thursday, May 12, 2022. The Company’s management will discuss the results during a conference call and simultaneous webcast at 4:30 p.m. ET that same day. Presentation slides will also be posted to the ‘Company Events’ sub-page of the Comp
